ApprovalTrail

Approval · Notice of Compliance 3134 · 1998

ELMIRON: Notice of Compliance 3134

Issued January 19, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3134
Date
January 19, 1998
Company
Alza CanadaOakville, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Glycosaminoglycan substitute

Products in this notice

BrandDINStatus today
ELMIRON02029448Marketed

Medicinal ingredients